Formulation of treatment recommendations for statins - Reply

JAMA

Volumn 311, Issue 3, 2014, Pages 306-

  Ridker, Paul M ^a   Wilson, Peter W F ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTERY INTIMA PROLIFERATION; BONE DENSITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; HUMAN; INFORMATION PROCESSING; LETTER; MEDICAL RESEARCH; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; QUALITY CONTROL; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84892654279     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.284481     Document Type: Letter

References (2)

1. Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;1:CD004816.
2. Ridker PM. What works and in whom? a simple, easily applied, evidence-based approach to guidelines for statin therapy. Circ Cardiovasc Qual Outcomes. 2012;5(4):592-593.